secwatch / observer
8-K filed July 1, 2024, 7:59 PM ET CIK 0001651311
leadership confidence high sentiment neutral materiality 0.65

Merus appoints Fabian Zohren as CMO with $503K salary; CBO Liu and former CMO Joe depart

Merus N.V.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Fabian Zohren

Chief Medical Officer
Merus N.V.
Effective
2024-07-01
Filed
July 1, 2024, 7:59 PM ET
On June 30, 2024, the Board of Directors (the “Board”) of Merus N.V. (the “Company”) appointed Fabian Zohren, M.D., Ph.D. to serve as the Company’s Chief Medical Officer, effective as of July 1, 2024
Departed

Andrew Joe

Chief Medical Officer
Merus N.V.
Effective
2024-07-01
Successor
Fabian Zohren
Filed
July 1, 2024, 7:59 PM ET
succeeding Andrew Joe, M.D. in such role

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Fabian Zohren was appointed as Chief Medical Officer at Merus N.V..

Action
appointed
Role
Chief Medical Officer
Exact text from the filing
On June 30, 2024, the Board of Directors (the “Board”) of Merus N.V. (the “Company”) appointed Fabian Zohren, M.D., Ph.D. to serve as the Company’s Chief Medical Officer, effective as of July 1, 2024
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.9

Andrew Joe departed as Chief Medical Officer at Merus N.V..

Action
separated
Role
Chief Medical Officer
Exact text from the filing
succeeding Andrew Joe, M.D. in such role
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-24-172782
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.